Sfoglia per Autore
Rischio neoplastico post-trapianto
2001 C., Bengala; Guarneri, Valentina; I., Pazzagli
New combinations with epirubicin in advanced breast cancer.
2001 Conte, Pierfranco; Gennari, A; Landucci, E; Guarneri, Valentina; Donati, S; Salvadori, B; Bengala, C; Orlandini, C.
Epirubicin/taxane combinations in breast cancer: experience from several Italian trials
2001 Conte, Pierfranco; Gennari, A; Guarneri, Valentina; Landucci, E; Donati, S; Salvadori, B; Bengala, C; Orlandini, C; Baldini, E.
High-dose thiotepa and melphalan with hemopoietic progenitor support following induction therapy with epirubicin-paclitaxel-containing regimens in metastatic breast cancer (MBC)
2001 C., Bengala; I., Pazzagli; F., Innocenti; S., Donati; C., Favre; M. C., Menconi; F., Greco; R., Danesi; C., Orlandini; Guarneri, Valentina; M., Del Tacca; Conte, Pierfranco
Weekly docetaxel/paclitaxel in pretreated metalistic breast cancer
2002 Gennari, A; Guarneri, Valentina; Landucci, E; Orlandini, C; Rondini, M; Salvadori, B; Ricci, S; Conte, Pierfranco
Outcomes of metastatic breast cancer patients older than 60 years treated with FEC or ET regimens: A retrospective analysis
2003 A., Gennari; Guarneri, Valentina; C., Orlandini; B., Salvadori; S., Donati; M., Rondini; S., Ricci; E., Landucci; Conte, Pierfranco
High – dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding study
2003 C., Bengala; R., Danesi; Guarneri, Valentina; I., Pazzagli; S., Donati; C., Favre; S., Fogli; O., Biadi; F., Innocenti; M., DEL TACCA; M., Mariani; Conte, Pierfranco
Le Cellule Staminali Mesenchimali: Aspetti Biologici ed Approcci Terapeutici
2004 Dominici, Massimo; Guarneri, Valentina; Cafarelli, Luigi; Conte, Pierfranco
Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy
2004 A., Gennari; P., Bruzzi; C., Orlandini; B., Salvadori; S., Donati; E., Landucci; Guarneri, Valentina; M., Rondini; S., Ricci; Conte, Pierfranco
Renal safety of zoledronic acid in patients with bone metastases from breast cancer (BC) or other tumors treated with IV BisphosphonateS (BPS) for up to ten years
2004 Guarneri, Valentina; Donati, S; Nicolini, M; Conte, Pierfranco
Safety of intravenous and oral bisphosphonates and compliance with dosing regimens
2004 Conte, Pierfranco; Guarneri, Valentina
HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support
2004 Guarneri, Valentina; C., Bengala; C., Orlandini; A., Gennari; S., Donati; D., Campani; P., Collecchi; M., Maur; Conte, Pierfranco
Concomitant versus sequential administration of epirubicin and paclitaxel as first-line therapy in metastatic breast carcinoma - Results from the Gruppo Oncologico Nord Ovest randomized trial
2004 Conte, Pierfranco; Guarneri, Valentina; P., Bruzzi; T., Prochilo; B., Salvadori; A., Bolognesi; D., Aldrighetti; M., Venturini; R., Rosso; S., Mammoliti; F., Carnino; P., Giannessi; M., Costantini; A., Moyano; E., Baldini
Changes in survival and time to progression in metastatic breast cancer (MBC) patients enrolled into clinical trials from 1983 to 2001
2004 A., Gennari; Conte, Pierfranco; C., Orlandini; Guarneri, Valentina; R., Rosso; P., Bruzzi; for the North West Oncology Group, Gono
The curability of breast cancer and the treatment of advanced disease
2004 Guarneri, Valentina; Conte, Pierfranco
Operable Breast Cancer: preliminary results of a phase II, double blind, placebo controlled, randomized trial of preoperative chemotherapy +/- gefitinib with biomarkers evaluation
2005 Guarneri, Valentina; Frassoldati, A; Ficarra, G; Giovannelli, Simona; Borghi, F; Puglisi, F; Mansutti, M; Andreetta, C; Banna, G; Masci, G; Santoro, A; Boni, C; Bisagni, G; Michelotti, A; Crispino, S; Conte, Pierfranco
Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study
2005 Conte, Pierfranco; S., Donati; A., Gennari; Guarneri, Valentina; C., Orlandini; M., Rondini; M., Roncella; L., Marini; P., Collecchi; P., Viacava; A. G., Naccarato; R., DEGLI ESPOSTI; S., Bonardi; A., Bottini; S., Saracchini; S., Tumolo; G., Gullo; A., Santoro; L., Crino
Predictive value of biological parameters for primary chemotherapy in operable breast cancer
2005 A., Frassoldati; M., Maur; Guarneri, Valentina; M., Nicolini; Conte, Pierfranco
In response to Body letter to the editor regarding "Safety of intravenous and oral Bisphosphonates and compliance with dosing regimens"
2005 Conte, Pierfranco; Guarneri, Valentina
In response to Jackson letter to the editor regarding "Safety of intravenous and oral bisphosphonates and compliance with dosing regimens"
2005 Conte, Pierfranco; Guarneri, Valentina
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Rischio neoplastico post-trapianto | 1-gen-2001 | C., Bengala; Guarneri, Valentina; I., Pazzagli | |
New combinations with epirubicin in advanced breast cancer. | 1-gen-2001 | Conte, Pierfranco; Gennari, A; Landucci, E; Guarneri, Valentina; Donati, S; Salvadori, B; Bengala, C; Orlandini, C. | |
Epirubicin/taxane combinations in breast cancer: experience from several Italian trials | 1-gen-2001 | Conte, Pierfranco; Gennari, A; Guarneri, Valentina; Landucci, E; Donati, S; Salvadori, B; Bengala, C; Orlandini, C; Baldini, E. | |
High-dose thiotepa and melphalan with hemopoietic progenitor support following induction therapy with epirubicin-paclitaxel-containing regimens in metastatic breast cancer (MBC) | 1-gen-2001 | C., Bengala; I., Pazzagli; F., Innocenti; S., Donati; C., Favre; M. C., Menconi; F., Greco; R., Danesi; C., Orlandini; Guarneri, Valentina; M., Del Tacca; Conte, Pierfranco | |
Weekly docetaxel/paclitaxel in pretreated metalistic breast cancer | 1-gen-2002 | Gennari, A; Guarneri, Valentina; Landucci, E; Orlandini, C; Rondini, M; Salvadori, B; Ricci, S; Conte, Pierfranco | |
Outcomes of metastatic breast cancer patients older than 60 years treated with FEC or ET regimens: A retrospective analysis | 1-gen-2003 | A., Gennari; Guarneri, Valentina; C., Orlandini; B., Salvadori; S., Donati; M., Rondini; S., Ricci; E., Landucci; Conte, Pierfranco | |
High – dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding study | 1-gen-2003 | C., Bengala; R., Danesi; Guarneri, Valentina; I., Pazzagli; S., Donati; C., Favre; S., Fogli; O., Biadi; F., Innocenti; M., DEL TACCA; M., Mariani; Conte, Pierfranco | |
Le Cellule Staminali Mesenchimali: Aspetti Biologici ed Approcci Terapeutici | 1-gen-2004 | Dominici, Massimo; Guarneri, Valentina; Cafarelli, Luigi; Conte, Pierfranco | |
Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy | 1-gen-2004 | A., Gennari; P., Bruzzi; C., Orlandini; B., Salvadori; S., Donati; E., Landucci; Guarneri, Valentina; M., Rondini; S., Ricci; Conte, Pierfranco | |
Renal safety of zoledronic acid in patients with bone metastases from breast cancer (BC) or other tumors treated with IV BisphosphonateS (BPS) for up to ten years | 1-gen-2004 | Guarneri, Valentina; Donati, S; Nicolini, M; Conte, Pierfranco | |
Safety of intravenous and oral bisphosphonates and compliance with dosing regimens | 1-gen-2004 | Conte, Pierfranco; Guarneri, Valentina | |
HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support | 1-gen-2004 | Guarneri, Valentina; C., Bengala; C., Orlandini; A., Gennari; S., Donati; D., Campani; P., Collecchi; M., Maur; Conte, Pierfranco | |
Concomitant versus sequential administration of epirubicin and paclitaxel as first-line therapy in metastatic breast carcinoma - Results from the Gruppo Oncologico Nord Ovest randomized trial | 1-gen-2004 | Conte, Pierfranco; Guarneri, Valentina; P., Bruzzi; T., Prochilo; B., Salvadori; A., Bolognesi; D., Aldrighetti; M., Venturini; R., Rosso; S., Mammoliti; F., Carnino; P., Giannessi; M., Costantini; A., Moyano; E., Baldini | |
Changes in survival and time to progression in metastatic breast cancer (MBC) patients enrolled into clinical trials from 1983 to 2001 | 1-gen-2004 | A., Gennari; Conte, Pierfranco; C., Orlandini; Guarneri, Valentina; R., Rosso; P., Bruzzi; for the North West Oncology Group, Gono | |
The curability of breast cancer and the treatment of advanced disease | 1-gen-2004 | Guarneri, Valentina; Conte, Pierfranco | |
Operable Breast Cancer: preliminary results of a phase II, double blind, placebo controlled, randomized trial of preoperative chemotherapy +/- gefitinib with biomarkers evaluation | 1-gen-2005 | Guarneri, Valentina; Frassoldati, A; Ficarra, G; Giovannelli, Simona; Borghi, F; Puglisi, F; Mansutti, M; Andreetta, C; Banna, G; Masci, G; Santoro, A; Boni, C; Bisagni, G; Michelotti, A; Crispino, S; Conte, Pierfranco | |
Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study | 1-gen-2005 | Conte, Pierfranco; S., Donati; A., Gennari; Guarneri, Valentina; C., Orlandini; M., Rondini; M., Roncella; L., Marini; P., Collecchi; P., Viacava; A. G., Naccarato; R., DEGLI ESPOSTI; S., Bonardi; A., Bottini; S., Saracchini; S., Tumolo; G., Gullo; A., Santoro; L., Crino | |
Predictive value of biological parameters for primary chemotherapy in operable breast cancer | 1-gen-2005 | A., Frassoldati; M., Maur; Guarneri, Valentina; M., Nicolini; Conte, Pierfranco | |
In response to Body letter to the editor regarding "Safety of intravenous and oral Bisphosphonates and compliance with dosing regimens" | 1-gen-2005 | Conte, Pierfranco; Guarneri, Valentina | |
In response to Jackson letter to the editor regarding "Safety of intravenous and oral bisphosphonates and compliance with dosing regimens" | 1-gen-2005 | Conte, Pierfranco; Guarneri, Valentina |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile